NKG2D chimeric antigen receptor-T cells to target GBM.

被引：0
|
作者：
Dai, Hong-jiu
Yang, Dong
Sun, Bin
Shi, Lan
Zhang, Pei-xian
Zhao, Xu-dong
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.2034
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2034
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Development of NKG2D chimeric antigen receptor-T cells as targeted therapy of liver cancer
    Dai, Hong-jiu
    Yang, Dong
    Sun, Bin
    Jiang, Yu-Bo
    Jia, Ru
    Xu, Jian-Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] A first-in-human phase I trial of NKG2D chimeric antigen receptor-T cells in AML/MDS and multiple myeloma
    Nikiforow, Sarah
    Murad, Joana
    Daley, Heather
    Negre, Helene
    Reder, Jake
    Sentman, Charles L.
    Lehmann, Frederic
    Snykers, Sarah
    Allen, Rachel
    Galinsky, Ilene
    Munshi, Nikhil C.
    Stone, Richard M.
    Soiffer, Robert
    Ritz, Jerome
    Baumeister, Susanne H. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] Development of NKG2D-based chimeric antigen receptor-T cells for gastric cancer treatment
    Tao, Kelong
    He, Meng
    Tao, Feng
    Xu, Guangen
    Ye, Minfeng
    Zheng, Yuanyuan
    Li, Yaoqing
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (05) : 815 - 827
  • [4] Development of NKG2D-based chimeric antigen receptor-T cells for gastric cancer treatment
    Kelong Tao
    Meng He
    Feng Tao
    Guangen Xu
    Minfeng Ye
    Yuanyuan Zheng
    Yaoqing Li
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 815 - 827
  • [5] NKG2D Chimeric Antigen receptor-expressing Lymphocytes Target Acute Myeloid Leukemia Cells
    Leivas, Alejandra
    Cordoba, Laura
    Valeri, Antonio
    Liz Paciello, Mari
    Rio, Paula
    Primo, Daniel
    Ballesteros, Joan
    Fernandez, Lucia
    Perez-Martinez, Antonio
    Lee, Dean A.
    Powell, Daniel J., Jr.
    Martinez-Lopez, Joaquin
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 260 - 261
  • [6] Chimeric antigen receptor T cell therapy targeting NKG2D ligand
    Asao, Tetsuhiko
    Ishibashi, Rie
    Inoue, Moeko
    Fuse, Masafumi
    Miura, Yoshie
    Ishizaki, Hidenobu
    Yoshimura, Kiyoshi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] T cells expressing an NKG2D chimeric antigen receptor efficiently eliminate glioblastoma cells and cancer stem cells
    Yang, D.
    Sun, B.
    Dai, H.
    Zhao, X.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1712 - 1713
  • [8] Safety Data from a First-in-Human Phase 1 Trial of NKG2D Chimeric Antigen Receptor-T Cells in AML/MDS and Multiple Myeloma
    Nikiforow, Sarah
    Werner, Lillian
    Murad, Joana
    Jacobs, Matthew
    Johnston, Lauren
    Patches, Sarah
    White, Randie
    Daley, Heather
    Negre, Helene
    Reder, Jake
    Sentman, Charles
    Wade, Terri
    Schmucker, Adam
    Lehmann, Frederic Francois
    Snykers, Sarah
    Allen, Rachel
    Dipietro, Heidi
    Cummings, Kristen
    Galinsky, Ilene
    Munshi, Nikhil C.
    Schlossman, Robert L.
    Stone, Richard M.
    Neuberg, Donna S.
    Soiffer, Robert J.
    Dranoff, Glenn
    Ritz, Jerome
    Baumeister, Susanne H. C.
    BLOOD, 2016, 128 (22)
  • [9] NKG2D as a chimeric antigen receptor - DAP 10 provides optimal co stimulation for NKG2D based CARs
    Bolsee, Jennifer
    Breman, Eytan
    Huberty, Fanny
    Violle, Benjamin
    Marijsse, Jerome
    Jacques-Hespel, Celine
    Marchand, Celine
    Ramelot, Nancy
    Thuy Nguyen
    Houssa, Julien
    Gilham, David E.
    Agaugue, Sophie
    CANCER RESEARCH, 2018, 78 (13)
  • [10] Chimeric NKG2D receptor-expressing T cells as an immunotherapy for multiple myeloma
    Barber, Amorette
    Zhang, Tong
    Megli, Christina J.
    Wu, Jillian
    Meehan, Kenneth R.
    Sentman, Charles L.
    EXPERIMENTAL HEMATOLOGY, 2008, 36 (10) : 1318 - 1328
12345